Celecoxib-induced gastrointestinal, liver and brain lesions in rats, counteraction by BPC 157 or L-arginine, aggravation by L-NAME

AIM: To counteract/reveal celecoxib-induced toxicity and NO system involvement. METHODS: Celecoxib (1 g/kg b.w. ip) was combined with therapy with stable gastric pentadecapeptide BPC 157 (known to inhibit these lesions, 10 μg/kg, 10 ng/kg, or 1 ng/kg ip) and L-arginine (100 mg/kg ip), as well as NOS...

Descripción completa

Detalles Bibliográficos
Autores principales: Drmic, Domagoj, Kolenc, Danijela, Ilic, Spomenko, Bauk, Lara, Sever, Marko, Zenko Sever, Anita, Luetic, Kresimir, Suran, Jelena, Seiwerth, Sven, Sikiric, Predrag
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Basic Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5550779/
https://www.ncbi.nlm.nih.gov/pubmed/28839430
http://dx.doi.org/10.3748/wjg.v23.i29.5304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5550779/
https://www.ncbi.nlm.nih.gov/pubmed/28839430
http://dx.doi.org/10.3748/wjg.v23.i29.5304

Ejemplares similares